GH Research (GHRS) Payables (2020 - 2026)
GH Research (GHRS) reported Payables of $5.93 million for Q2 2026, up 72.1% from $3.45 million a year earlier and up 13.8% from the prior quarter.
Analysis
GH Research (GHRS) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, GH Research posted Payables of $3.77 million, up 0.9% from FY2024.
- Payables has increased for four consecutive years, with a four-year compound annual growth rate of 43.8% (FY2021 to FY2025).
- By year, Payables came in at $3.74 million in FY2024 (+7.2%), $3.49 million in FY2023 (+86.8%), $1.87 million in FY2022 (+111.6%) and $883,000 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Payables in data going back to Q3 2021.
- Year over year, Payables has now increased in each of the last eight quarters, with growth averaging 24.6% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q4 2022 (growth of 111.6%); the low point was Q2 2024 (a decline of 11.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.21 million (Q1 2026), $3.77 million (Q4 2025) and $3.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 7.03 Bn |
| 10 | GH Research | 1.16 Bn | 35.01 Mn | - | 5.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.93 Mn |
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 3.74 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 3.55 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 883,000.00 |
| Sep 30, 2021 | 1.21 Mn |
API Access
GH Research Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GHRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();